Skip to main content
PLOS One logoLink to PLOS One
. 2026 Jul 31;21(7):e0354514. doi: 10.1371/journal.pone.0354514

Reproducibility of fetal global longitudinal strain measured with speckle tracking echocardiography using a fixed cardiac cycle

Eline Meireson 1,2,*, Chantelle de Vet 3, Judith O E H van Laar 3,4, Phaedra Mussche 2, Kristien Roelens 1,2, Noortje H M van Oostrum 1,2
Editor: Francesca Crovetto5
PMCID: PMC13426953  PMID: 42536642

Abstract

Fetal speckle tracking echocardiography is an ultrasound-based technique used to assess myocardial velocity and deformation of the fetal heart. Despite its potential, the method has not yet been integrated into routine pregnancy care, partly due to concerns about inconsistent reproducibility. This study aimed to evaluate the intra- and inter-observer reproducibility of global longitudinal strain measurements derived from a fixed fetal cardiac cycle, using speckle tracking echocardiography.

Healthy women with singleton pregnancies were enrolled during the second trimester. From enrolment until delivery, four-chamber view clips of the fetal heart were acquired every four weeks. For intra-observer reproducibility, a single observer analyzed the same heart cycle in one DICOM clip twice for global longitudinal strain in the left and right ventricles, with a minimum interval of two weeks between assessments in a blinded manner. For inter-observer reproducibility, two independent observers analyzed the same cardiac cycle within one DICOM clip.

A total of 124 women were included, yielding 632 ultrasound clips. Intra-observer reproducibility was poor to moderate for global longitudinal strain for the right and left ventricles. Inter-observer reproducibility demonstrated moderate to good reproducibility for global longitudinal strain in both ventricles. The reproducibility was generally higher in the left ventricle than in the right, and the highest reproducibility was observed before 32 weeks of gestation.

In conclusion, speckle tracking echocardiography during pregnancy showed variable reproducibility of strain analysis when performed on a fixed cardiac cycle, with more consistent results in the left ventricle. These findings support the potential utility of fetal speckle tracking echocardiography, while highlighting the need for further refinement of reproducibility before clinical implementation.

Introduction

Fetal speckle tracking echocardiography (fSTE) is a promising ultrasound technique in fetal cardiac assessment. The offline tool uses the speckles in the ultrasound image to measure the deformation and velocity values of the myocardial wall [1]. fSTE offers notable advantages compared to the commonly used ultrasound techniques to evaluate fetal heart function. Advantages include the relative angle independence during image acquisition and its non-invasive nature, requiring only a four-chamber view of the fetal heart [2–6]. fSTE has been proven to be feasible, and reference values for global longitudinal strain (GLS) in healthy singleton fetuses have been established [5–9].

Despite its promise, fSTE remains primarily confined to research settings. This limited clinical adoption is likely due to inter-vendor variability and inconsistent findings regarding both deformation measurements and reproducibility [5,10–16]. As a result, internationally accepted guidelines are still lacking, and fSTE has not yet been integrated into routine prenatal care.

A critical factor in the reproducibility of fSTE measurements is the adherence to a strict protocol of image acquisition and fSTE analysis. High-quality four-chamber ultrasound clips are essential, and several technical parameters, such as frame rate and region of interest, must be carefully optimized [17–20]. Acquiring suitable images is especially challenging in fSTE compared to adult STE due to the small size of the fetal heart, frequent fetal movements, and the increasing difficulty of imaging in later gestational stages [3,9,21–23]. Furthermore, fSTE analysis involves multiple manual steps within the software, each of which may influence the GLS measurements and contribute to the variability in the outcomes [18].

The available literature on the reproducibility of fSTE is limited and presents inconsistent findings [5,11–16,22,24–26]. Reported intra- and inter-observer reproducibility varies from poor to excellent [5,11–16,22,24–26]. These inconsistencies may be explained by the methodological differences or the fact that the reproducibility has been assessed at different stages of the fSTE analysis, rather than systematically evaluating each step. As a result, it remains unclear which components of the fSTE procedure are the main sources of variability.

To address existing gaps in knowledge regarding the reproducibility of fSTE, this study evaluates both intra- and inter-observer reproducibility using a standardized approach. In contrast to previous studies, reproducibility is assessed under controlled conditions by analyzing the same cardiac cycle within a single high-quality four-chamber ultrasound clip in healthy fetuses. This design enables a more precise assessment of variability attributable to the analysis process itself, independent of acquisition-related factors.

Materials and methods

Study population

This prospective cohort study was conducted at Máxima Medical Centre, a tertiary care facility located in Veldhoven, The Netherlands. The study protocol for the collection of ultrasound clips was described before by van Oostrum et. al.[9,27]. In short: the study included healthy pregnant women at 18  + 0 – 21  + 6  weeks of gestation, and followed them until delivery. Every four weeks, fetal heart ultrasound scans were performed. The exclusion criteria were the following: multiple pregnancies, insufficient understanding of the Dutch language, fetal arrhythmia, any suspicion of fetal congenital anomalies that might influence fetal cardiac function, pre-existing maternal hypertensive disease and autoimmune disease, including systemic lupus erythematosus or diabetes mellitus. Women who developed fetal growth restriction, hypertensive disease, or gestational diabetes after inclusion were excluded from the cohort. Furthermore, women who delivered a neonate with birth weight < 10th percentile (corrected for gender and gestational age at birth) or with congenital or genetic abnormality were excluded from the cohort. The medical ethics committee of the Máxima Medical Centre, Veldhoven, The Netherlands, approved the study (NL64999.015.18). All participants provided oral and written informed consent. The recruitment period started on 22-05-2018 and ended at 31-04-2019. Anonymized data was accessed on the 18th November 2024 and used for this study.

Fetal Echocardiography and fSTE analysis

The fetal ultrasounds were performed using a Philips EPIQ 7 W ultrasound (Philips, Eindhoven, The Netherlands) by experienced cardiac sonographers, following a standardized protocol specifically designed for fetal heart echocardiography [27]. Ultrasound assessments were scheduled every 4 weeks from enrolment (18 weeks – 22 weeks) until delivery or up to 41 weeks of gestational age [27].

Offline fSTE analysis was conducted using dedicated fetal cardiac software (2D Cardiac Performance 1.2, TomTec Imaging Systems GmbH, Munich, Germany). The fSTE analysis was performed on stored DICOM clips, following a previously described standardized protocol for clip acquisition [27]. Three DICOM clips per ultrasound were stored.

The different steps of the fSTE analysis in this study were the following: 1) The DICOM clip with the highest possible frame rate, visibility of the atrioventricular valves, absence of outflow vessels, and visibility of the entire four-chamber view was identified out of the 3 stored DICOM clips.

2) Within this selected high-quality DICOM clip, 1 single cardiac cycle was selected. The M-mode and its corresponding R-wave functionality were used to identify the opening and closure of the atrioventricular valves, corresponding to one heart cycle (Fig 1).

Fig 1. Step 2 of the fSTE analysis: selection of one heart cycle in M mode.

Fig 1

3) Once one cardiac cycle was identified, the endocardial border of the left ventricle (LV) was defined by selecting three anatomical reference points (the junction of the lateral wall annulus, the junction of the septal wall annulus, and the apex of the heart). Based on these points, the software proposed an endocardial line in systole. If needed, this line could be manually adjusted (Fig 2).

Fig 2. Step 3 of the fSTE analysis: delineation of the endocardial border in systole in the LV.

Fig 2

4) After the endocardial border was set in systole, the software automatically generated the endocardial border in diastole. Manual corrections were again applied when the proposed contour did not accurately follow the endocardial wall (Fig 3).

Fig 3. Step 4 of the fSTE analysis: delineation of the endocardial border in diastole in the LV.

Fig 3

5) After the completion of the endocardial wall identification in both systole and diastole, the software computed the LV-GLS (Fig 4).

Fig 4. Step 5 of fSTE analysis: calculation of LV-GLS.

Fig 4

6) Following the LV-GLS analysis, steps 3–5 were repeated for the right ventricle (RV), including the selection of reference points in the RV, contour verification in systole and diastole, and calculation of RV-GLS (Fig 5).

Fig 5. Step 6 of the fSTE analysis: delineation of the endocardial border of the RV.

Fig 5

The offline fSTE analysis was performed by two fSTE experts (NvO and EM). NvO is an experienced specialist in fetal cardiac sonography with extensive expertise in fSTE analysis. EM is a PhD student whose research focuses on fSTE; at the start of her doctoral training, she received dedicated instruction in fSTE methodology. EM performed the fSTE analyses following the completion of NvO’s analyses.

To evaluate intra-observer reproducibility, NvO conducted the fSTE analysis twice, following the standardized protocol described above. The second analysis was performed in a blinded manner, starting from step 3 of the protocol, with a minimum interval of two weeks between both analyses. To assess inter-observer reproducibility, two observers (NvO and EM) independently performed GLS measurements, blinded to each other’s outcome measures, and with a minimum interval of two weeks between both analyses. For the inter-observer reproducibility analysis, the second observer (EM) used the cardiac DICOM clips and heart cycles as identified by the first observer (in steps 1 and 2). fSTE analysis was performed by the second observer (EM) from steps 3 onwards. The second observer was blinded to the GLS values of the first observer. For this analysis, one ultrasound clip per participant was selected within a gestational age range of 23–30 weeks. With this protocol, we ensured the same DICOM clip and heart cycle were used, prohibiting differences in deformation values due to measurements in different heart cycles. The obtained GLS measurements of the three analyses were used to calculate the intra- and inter-observer reproducibility.

Statistical analysis

Statistical analyses were conducted using RStudio (version 2025.05.1+513). Continuous variables were reported as means and standard deviations (±SD). To evaluate the reliability of measurement agreement, the intraclass correlation coefficient (ICC) was used. The clinical interpretation of ICC values was categorized as follows: values > 0.9 indicate excellent reliability, 0.75–0.90 good reliability, 0.50–0.75 moderate reliability, and values below 0.50 reflect poor reliability [5,28].

First, intra-observer reproducibility was assessed using the dataset containing LV and RV-GLS values calculated twice by the first observer (NvO). ICC values and their corresponding 95% confidence intervals (CIs) were estimated using a linear mixed-effects model (LMM), which accounted for both within-subject and between-subject variance components. Separate models were constructed to assess variability in LV- and RV-GLS measurements. Gestational age was included as a fixed effect, while patient study ID and analysis number (analysis one or two) within each patient were modelled as random intercepts. The ICC was calculated as the proportion of total variance attributable to between-subject variability. This approach corresponds to a single-measure, one-way random-effects ICC (ICC(1,1)), reflecting absolute agreement between repeated measurements. Bland–Altman plots were made to visualize the agreement of the overall GLS in both the LV and RV between analyses one and two, illustrating the mean difference along with the upper and lower limits of agreement. Bland–Altman plots were constructed for descriptive assessment of agreement. Given the presence of repeated measurements per subject, these analyses do not fully account for within-subject correlation and should be interpreted accordingly. Afterward, a paired t-test was performed to assess systematic bias between GLS values obtained from analyses one and two. A non-significant result (p > 0.05) indicates no statistically meaningful difference, suggesting comparable outcomes across both analyses.

In a sub-analysis, the intra-observer reproducibility was further evaluated across specific gestational age categories using the ICC function in RStudio, providing the ICC value along with its associated 95% confidence intervals. The following gestational age categories were created: 18–22, 23–27, 28–32, 33–37, and 38–41 weeks. Bland–Altman plots were generated for LV- and RV-GLS across these gestational age categories. These plots were used to visualize the agreement of the GLS measurements between analyses one and two, illustrating the mean difference along with the upper and lower limits of agreement per gestational age (GA) group. These plots were made for descriptives only. A paired t-test was performed to assess systematic bias between GLS values obtained from analyses one and two. A non-significant result (p > 0.05) indicated no statistically meaningful difference, suggesting comparable outcomes across both analyses.

Secondly, the inter-observer reproducibility was assessed. A sample size calculation was performed to determine the number of clips needed to be evaluated [29,30]. The threshold was set at 0.60 [25], expected reliability at 0.75, statistical power at 80%, and significance level at 0.05. Only independent data were used, with one DICOM clip per patient. The selected DICOM clips originated from gestational age categories that showed the highest reproducibility in the intra-observer sub-analysis. After the selection of the DICOM clips needed for the analysis, the same statistical methods as used for the intra-observer reproducibility analyses were applied, including an LMM, Bland-Altman plots, and paired t-tests.

Results

The cohort's study characteristics have been previously described [9]. In brief, a total of 632 clips from 124 patients were collected between 18 and 41 weeks GA. The mean maternal body mass index was 23.89 kg/m² (±4.28). The mean frame rate of the ultrasound clips was 87.20 frames per second (fps) (±20.90). The mean LV- and RV-GLS were respectively −21.26% (±7.02) and −19.05% (±5.46).

Intra-observer reproducibility

Table 1 summarizes the ICCs, and 95% CIs, of the LV- and RV-GLS (GA 18–41 weeks). The p-values from the paired t-test are both non-significant (p > 0.05) (Table 1).

Table 1. Intraclass coefficients (ICCs) for LV-and RV-GLS, along with their corresponding 95% confidence intervals (CIs), and p-value from the paired t-test.

ICC 95% CI p-value
LV GLS 0.651 [0.582 – 0.712] 0.435
RV GLS 0.460 [0.386 – 0.528] 0.199

The Bland-Altman plots of the overall LV-and RV-GLS (GA 18–41 weeks) of the intra-observer analysis are shown in Fig 6. The mean difference of LV-GLS was 0.19, with a lower and upper limit of −11.27% and 11.64%. The mean difference of RV-GLS was 0.33%, with a lower and upper limit of −11.67% and 12.32%.

Fig 6. Bland-Altman plots (intra-observer) of the overall LV-and RV-GLS (GA ranging from 18 to 41 weeks).

Fig 6

Table 2 summarizes the ICCs of the GLS of the LV and RV at specific GA categories as well as the p-value from the paired t-test.

Table 2. Intraclass coefficient of LV-and RV-(GLS), along with their 95% confidence interval (CI) and p-value from the paired t-test, per GA category.

GA (weeks) Clips (n) LV-GLS RV-GLS
ICC 95% CI p-value ICC 95% CI p-value
18-22 128 0.687 [0.584-0.769] 0.093 0.379 [0.217-0.52] 0.721
23-27 184 0.736 [0.661-0.797] 0.188 0.505 [0.389-0.606] 0.437
28-32 139 0.647 [0.539-0.734] 0.728 0.518 [0.381-0.633] 0.362
33-37 109 0.405 [0.235-0.551] 0.246 0.356 [0.169-0.519] 0.688
38-41 46 0.633 [0.422-0.779] 0.45 0.504 [0.223-0.707] 0.715

The LV-GLS Bland-Altman plots performed across the gestational age categories of the intra-observer sub-analysis showed the narrowest spread within the 23–27 weeks group (Fig 7). Mean differences across all categories were close to zero, with the smallest observed in the 28–32 weeks group (mean difference = 0.16%).

Fig 7. Bland-Altman plots (intra-observer) of the LV-GLS across different gestational age categories (18-22 weeks, 23-32 weeks, 33-37 weeks, 38-41 weeks).

Fig 7

The RV-GLS Bland-Altman plots performed across the gestational age categories of the intra-observer sub-analysis demonstrated the narrowest spread within the 18–22 weeks and 23–27 weeks group (Fig 8). Mean differences across all categories were close to zero, with the smallest observed in the 18–22 weeks group (mean difference = 0.21%).

Fig 8. Bland -Altman plots (intra-observer) of RV-GLS across different GA categories (18-22 weeks, 23-32 weeks, 33-37 weeks, 38-41 weeks).

Fig 8

Inter-observer reproducibility

The sample size calculation indicated that 102 independent ultrasound clips were required for the inter-observer reproducibility analysis. We selected of every participant 1 DICOM clip (124 clips), originating from the gestational ages of 23–30 weeks, with the majority (44 clips) performed at 27 weeks GA. Table 3 shows the ICCs calculated from an LMM along with their corresponding 95% CI, and their p-values from the paired t-test for the GLS values of both ventricles.

Table 3. Intraclass correlation coefficients (ICCs) for the LV-and RV-GLS, along with their corresponding 95% confidence intervals (CI), and p-value from the paired t-test.

ICC 95% CI p-value
LV GLS 0.871 [0.792 – 0.921] 0.589
RV GLS 0.662 [0.483 – 0.780] 0.0008

The Bland-Altman plots of the LV-and RV-GLS (GA 23–30 weeks) of the inter-observer analysis are shown in Fig 9. The mean difference in LV-GLS is −0.19%, compared to −1.38% for RV-GLS.

Fig 9. Bland-Altman plots of inter-observer differences in LV-and RV_GLS (GA ranging from 23 to 30 weeks).

Fig 9

Discussion

This study specifically assesses the intra- and inter-observer reproducibility of fetal GLS derived from the same heart cycle within a single DICOM clip analyzed using fSTE with a standardized approach. Concerning the intra-observer reproducibility, our findings demonstrated moderate reproducibility for LV-GLS and poor reproducibility for RV-GLS. Importantly, the intra-observer reproducibility of both LV- and RV-GLS varied across gestational ages, with the highest ICC values reported before 32 weeks of gestation. Regarding inter-observer reproducibility, good reproducibility was shown for LV-GLS, and moderate reproducibility for RV-GLS.

Although several studies have reported on the intra- and inter-reproducibility of LV- and RV-GLS before [5,11,12,14–16,22,25,26], the results are difficult to compare and interpret due to several factors:

Statistical methodology

Different studies have employed various statistical approaches to assess reproducibility, such as ICC, Lin’s Concordance Correlation Coefficient (CCC), Bland-Altman plots, Pearson’s correlation coefficient (r), and Cronbach’s alpha [5,11,12,14–16,22,26]. Among these, ICC is widely recognized as the most appropriate method for evaluating reproducibility in studies involving multiple raters, repeated measurements, and continuous outcomes [31,32]. Bland-Altman plots complement ICCs by visually representing agreement and identifying potential systematic bias [33]. Therefore, our study applied both ICC and Bland-Altman plots to assess reproducibility.

To date, eight studies have reported ICC values for LV- and RV-GLS reproducibility using fSTE [5,12,14–16,22,24,26]. The ICC values of these studies are summarized in Table 4. Reported ICC values for LV-GLS intra-observer reproducibility ranged from 0.35 [24] to 0.93 [12], aligning with our findings. Inter-observer ICCs for LV-GLS ranged from 0.44 [14] to 0.91 [22], also consistent with our results. For RV-GLS, intra-observer ICCs ranged from 0.21 [24] to 0.89 [12,16] and inter-observer ICCs from 0.28 [24] to 0.89 [26], both in line with our findings.

Table 4. Overview of published articles reporting on intra- and inter-observer reproducibility using Intraclass correlation coefficients (ICC) and their 95% confidence interval (CI) of LV-and RV-GLS.

Article ICC LV GLS [95% CI] ICC RV GLS [95% CI] ICC categories used in the study
Intra-observer Inter-observer Intra-observer Inter-observer
Our study 0.65[0.58- 0.71] 0.87[0.79- 0.92] 0.46[0.39- 0.53] 0.66[0.48- 0.77] <0.50 poor

0.50-0.75 moderate

0.75-0.90 good

>0.90 excellent
Kapusta et al., 2012 [14] 0.60* 0.44* 0.84* 0.68* <0.40 poor

0.40-0.60 moderate

0.60-0.80 good

>0.80 excellent
Crispi et al., 2012 [12] 0.93 [0.88- 0.96] 0.89 [0.81- 0.93] 0.89 [0.82- 0.93] 0.87 [0.79- 0.93] No categories described
Kapusta et al., 2013 [22] 0.83* 0.91* 0.58* 0.85* <0.40 poor

0.40-0.60 moderate

0.60-0.80 good

>0.80 excellent
Enzensberger et al, 2017 [26]$ – 0.890* – 0.892* 0.7-0.80 good

>0.80 strong
Huntley et al., 2021 [15] 0.77[0.57-0.91] 0.65[0.43–0.79] 0.44[0.32–0.68] 0.58[0.32–0.74] 0.50-0.60 low

0.7-0.80 good

>0.80 strong
Hu et al., 2024 [16] 0.78

[0.53- 0.91]
0.66

[0.33- 0.85]
0.89

[0.74- 0.96]
0.84

[0.64- 0.93]
<0.40 poor

0.40-0.75 moderate

>0.75 good
Nichting et al., 2024 [5] 0.75[0.56-0.86] 0.67[0.45-0.82] 0.80[0.64-0.89] 0.75[0.57-0.86] <0.50 poor

0.50-0.75 moderate

0.75-0.90 good

>0.90 excellent
Mlodawski et al., 2025 [24] 0.35 [0.01-0.61] 0.5 [0.27-0.68] 0.21 [0.78-0.88] 0.28 [0.02-0.51] <0.40 poor

*No 95% confidence interval (CI) was mentioned in the article, $the inter-observer reproducibility was calculated in this study with Cronbach’s alpha and therefore not mentioned in the Table.

Three of the eight studies did not report the 95% CI for their ICC estimates [14,22,26]. According to the guideline for selecting and reporting the ICC for reproducibility analysis, reproducibility should be reported by specifying the software used for analysis, along with the ICC estimate and its 95% CI [31]. Without the 95% CI, the stability and precision of the ICC values cannot be assessed [14,22,26].

Importantly, there are no universally accepted thresholds for interpreting ICC values [31]. Classification criteria varied across studies (Table 4), with definitions of “poor” ICC ranging from <0.4 to <0.6, and “good” ICC from >0.6 to >0.95 [15,22,25]. Due to this inconsistency, only the raw ICC values can be meaningfully compared. Nevertheless, we encourage researchers to adopt consistent ICC classification criteria when the same methodology is used to enhance comparability and interpretability. Across studies [5,12,14–16,22,26], both intra- and inter-observer reproducibility were generally higher for LV-GLS than for RV-GLS [12,15,22,24], likely due to the more complex delineation of the RV endocardial border in fSTE software, particularly influenced by anatomical features such as the moderator band [34]. It is important to note that a low ICC does not necessarily indicate poor reliability. It may also result from low variability among subjects, a small sample size, or a limited number of raters [31].

Most studies reported higher intra-observer reproducibility [5,12,14–16]. Remarkably, our study found higher inter- than intra-observer reproducibility, in line with two other studies [22,24]. We suggest that the reason for a higher inter-observer reproducibility in our study could be the following: the inter-observer reproducibility was assessed with clips (GA ±27 weeks), which showed the highest reproducibility in the intra-observer analysis

Bland-Altman plots of the inter-observer reproducibility were provided by the studies of Crispi et al.[12], Hu et al.[16], Huntley et al.[15], and Nichting et al.[5], showing mean differences in the LV-GLS ranging from −4.48 [15] to 0.3 [12] and in the RV-GLS from −4.0 [16] and −0.7 [12]. Our results are comparable, with a mean difference of −0.19 in LV-GLS and −1.38 in the RV-GLS. Interestingly, our upper and lower limits showed the narrowest spread compared to the other studies. Bland-Altman plots evaluating intra-observer reproducibility were only provided in our study and that of Huntley et al.[15]. These showed mean differences of 0.19 and 6.42 for LV-GLS, and 0.33 and 4.89 for RV-GLS, respectively [15]. A mean difference closer to zero indicates greater agreement between measurements, suggesting higher reproducibility and consistency across observers or repeated analyses [33]. However, despite these small mean differences and only poor to moderate ICC values, the limits of agreement in our intra-observer study remained relatively wide (approximately ± −11–12%). Indicating substantial variability between repeated measurements. Consequently, individual GLS measurements may not be interchangeable, as repeated assessments can differ considerably. From a clinical perspective, small differences should therefore be interpreted with caution, as they may reflect measurement variability rather than true change. These findings highlight the importance of evaluating both consistency (ICC) and absolute agreement (Bland–Altman analysis) when assessing reproducibility.

fSTE analysis step

Previous studies [5,11–16,22,26] have not specified which specific step of the fSTE analysis was selected for their reanalysis, leaving uncertainty about the comparability of the study results. As mentioned before, fSTE analysis requires manual adjustments in each step. Depending on the fSTE step used for the reproducibility measurements, outcomes might be different and variable. Our study is the first to evaluate GLS reproducibility using a fixed heart cycle within a single DICOM clip and to explicitly define and report the specific analysis step selected for reanalysis. This approach enhances methodological transparency and allows for a more accurate assessment of measurement reliability and the ability to reproduce the study. We encourage researchers to describe the methodology of their intra- and inter-reproducibility analysis in more detail. Specifically, describing the exact step in the fSTE analysis that was reanalyzed. This would lead to more transparency and the possibility of comparing the results.

Sample size and gestational age

The number of included clips in the reproducibility analyses across previous studies varies considerably, ranging from 10 to 56 (Table 5) [5,11–16,22,24–26]. Based on the approaches described by Walter et al.[30] and Bonnett [35], a formal sample size calculation for assessing inter-observer reproducibility was performed for this study. This approach ensured adequate statistical power and strengthened the reliability of our findings [32]. We determined that a minimum of 102 clips was required to ensure a robust analysis of reproducibility using ICC as the reliability metric. This number is in great contrast with the included clips of previously published studies and makes its reliability questionable. Even more, other studies reanalyzed a random number of clips available from their cohort, without performing a sample size calculation [5,14–16,22].

Table 5. Characteristics of published articles analyzing the intra- and inter-observer reproducibility.

Article Number of clips included Ultrasound device STE software GA (weeks) Frame rate criteria Angle of insonation
Our study 632* or 124** Philips Epiq W7 TomTec 2D Cardiac Performance 1.2 software 18-41 The highest possible Not considered
Kapusta et al., 2012 [14] 12 Vivid I digital ultrasound scanner (GE) EchoPac (GE) 20-24 ≥ 90 Hz Apical or basal
Crispi et al, 2012 [12] 56 Vivid I digital ultrasound scanner (GE) EchoPac (GE) 23-40 >70Hz Apical or basal
Kapusta et al., 2013 [22] 10 Vivid I digital ultrasound scanner (GE) EchoPac (GE) 30-34 ≥ 90 Hz Apical or basal
Enzensberger et al.2017 [26] 10 Toshiba Medical Systems Corporation, Otawara,

Tochigi, Japan
TestDriver software (Toshiba Medical Systems

Corporation, Japan)
18-36 >60Hz Apical
Huntley et al., 2021 [15] 14* or 50** GE Voluson E10 FetalHQ software 20-38 ≥ 80 Hz Perpendicular or tangential
Hu et al., 2024 [16] 20 GE Voluson E10 FetalHQ software 20-41 ≥ 80 Hz Not described
Nichting et al., 2024 [5] 37 Philips Epiq W7 TomTec 2D Cardiac Performance 1.2 software 16 ≥ 80 Hz Not described
Mlodawski et al., 2025 [24] 34*, 53** GE Volusion Expert 22 FetalHQ software 19-23 The highest possible Perpendicular

* intra-observer reproducibility, **inter-observer reproducibility

Concerning the gestational age, our study observed variable reproducibility of the LV- and RV-GLS values between the gestational age categories. The highest intra-observer reproducibility was observed at 23–27 weeks for LV-GLS (ICC = 0.736; 95%CI [0.66−0.]) and at 28–32 weeks for RV-GLS (ICC = 0.518; 95%CI[0.381–0.633]). Lower ICC values were noted in later gestational stages, likely reflecting the increased difficulty of fetal cardiac imaging in the third trimester [36].

In previous studies [5,12,15,16,26], intra- and inter-observer reproducibility analyses were conducted using clips obtained across a wide range in gestational age(16–40 weeks), without accounting for gestational age in the analysis.

Kapusta et al. evaluated the intra-observer reproducibility in the second (20–24 weeks) and third trimester (30–34 weeks) [14,22]. Their reported ICC for LV-GLS in the second trimester was 0.60, slightly lower than our ICC value of 0.687 at 18–22 weeks and notably lower than our ICC value of 0.736 at 23–27 weeks. Interestingly, their ICC for RV-GLS was substantially higher (0.84) compared to our values of 0.379 at 18–22 weeks or 0.505 at 23–27 weeks of gestation. This is remarkable, since the delineation of the endocardial border of the RV is harder than in the LV [34]. In the third trimester, Kapusta et al.[22] reported ICC values of 0.83 for LV-GLS, which is notably higher than our ICC values of 0.647 at 28–32 weeks and 0.405 at 33–37 weeks. Similarly, for RV-GLS, their reported ICC of 0.58 is higher compared to our ICC values of 0.518 at 28–32 weeks and 0.356 at 33–37 weeks of gestation [14,22]. Despite the known challenges of cardiac imaging in the third trimester, Kapusta et al.[22] reported notably high ICC values. However, their reproducibility analysis was based on a small sample,12 clips in the second trimester and 10 in the third [14,22]. In contrast, our study included a substantially larger dataset, with 128 clips re-evaluated at 18–22 weeks, 184 at 23–27 weeks, 139 at 28–32 weeks, and 109 at 33–37 weeks.

Technical characteristics

Other factors influencing the comparability of the intra- and inter-observer reproducibility analyses are the technical characteristics of the fSTE, particularly the image quality in each study. Image quality depends on factors such as acquisition technique, gestational age, and ultrasound settings (e.g., frame rate) (Table 5) [4,11–16,22,25,26]. While these technical aspects do not directly influence the reproducibility outcomes within a single study, it is important to report them to facilitate meaningful comparisons across studies.

Another factor influencing the comparability of results is the inter-vendor variability. The studies mentioned above used different types of STE software: TomTec, FetalHQ, and EchoPac (Table 5) [5,14–16,22]. However, the study by Di Tonto et al. has shown promising reproducibility between TomTec and FetalHQ software [25], suggesting that harmonization across vendors may be achievable with further validation.

In our study, the angle of insonation was not considered during image acquisition, based on prior evidence suggesting the software's relative angle independence [4]. However, the influence of insonation angle remains debated, as several studies have reported that variations in angle, as well as differences in frame rate, may affect tracking performance and reproducibility [12,14,15,22,24,26].

Limitations

A few limitations in our study should be acknowledged. First, the quiver tool provided in the TomTec software was not employed during the fSTE analysis by the first observer and was therefore also omitted by the second observer. This may have influenced the precision of myocardial tracking and GLS measurements. However, there has been no difference in reproducibility shown using the quiver tool, only in the velocity of the analysis [15,37].

Second, the inter-observer reproducibility of the RV-GLS showed significant mean differences (paired t-test, p < 0.05; Bland-Altman mean difference of −1.46). This suggests the presence of systematic bias, where one observer may consistently overestimate GLS values relative to the other. While ICC values capture relative consistency, they do not account for absolute mean differences illustrated by the Bland-Altman plot, limiting clinical interchangeability. Previous studies by Nichting et al.[5] and Sacco et al.[11], also included a paired t-test to assess potential systematic bias, but reported p-values above 0.05, indicating no significant bias between observers.

Third, for the inter-observer reproducibility analysis, we selected one DICOM clip per participant (n = 124), restricted to gestational ages between 23 and 30 weeks. This interval was chosen based on the intra-observer analysis, which showed optimal reproducibility within this range. Consequently, the inter-observer analysis reflects reproducibility under favorable imaging conditions and may not be representative of the full gestational age range (18–41 weeks). Moreover, as image quality and fetal position can vary substantially in routine clinical practice, the applicability of these findings to less optimal imaging conditions may be limited.

A further limitation is that the inter-observer reproducibility analysis was not conducted under fully independent conditions. Observer two was trained by observer one after the latter had gained additional experience from repeated analyses, and the comparison was based on the second set of measurements of observer one. This may have led to increased alignment between observers and, consequently, an overestimation of inter-observer agreement. Finally, the study was conducted by highly experienced operators, which may limit the generalizability of the findings to routine clinical practice, where varying levels of expertise are encountered.

Research implications and future directions

This study demonstrates that fSTE yields poor to good reproducibility when the same heart cycle is analyzed within a single DICOM clip. From a clinical perspective, this variability implies that GLS measurements should be interpreted with caution, particularly when small differences are used to guide clinical decisions or to assess longitudinal changes. Before clinical implementation, further research is required to determine how individual steps within the analysis process affect reproducibility. A logical next step would be to evaluate the reproducibility of the heart cycle selection, which is often the first and potentially most variable stage of the workflow. Moreover, the manual delineation and adjustment of the endocardial border in both systole and diastole appear to represent critical sources of variability. Looking ahead, the application of artificial intelligence (AI) for automated selection of the most optimal heart cycle and detection of the endocardial border deserves further investigation, as such automation could minimize observer-dependent variation and improve the consistency and reliability of fSTE measurements.

Conclusion

Speckle tracking analysis of fetal LV-and RV-GLS demonstrates variable reproducibility after standardizing image and cycle selection. The measurements in the left ventricle showed more reliable reproducibility than those in the right ventricle. Across gestational age groups, descriptively higher ICC values were observed in the mid-gestation groups (23–32 weeks), However, to further define and compare intra- and inter-observer reproducibility in fSTE, additional studies are needed that clearly describe their protocols and use standardized methodologies.

Supporting information

S1 File. Dataset intra-observer reproducibility.

(XLSX)

pone.0354514.s001.xlsx (40.3KB, xlsx)
S2 File. Dataset interobserver reproducibility.

(XLSX)

pone.0354514.s002.xlsx (14.2KB, xlsx)

Data Availability

All relevant data are within the paper and its Supporting information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Blessberger H, Binder T. Two dimensional speckle tracking echocardiography: basic principles. Heart. 2010;96(9):716–22. doi: 10.1136/hrt.2007.141002 [DOI] [PubMed] [Google Scholar]
  • 2.Barker PCA, Houle H, Li JS, Miller S, Herlong JR, Camitta MGW. Global longitudinal cardiac strain and strain rate for assessment of fetal cardiac function: novel experience with velocity vector imaging. Echocardiography. 2009;26(1):28–36. doi: 10.1111/j.1540-8175.2008.00761.x [DOI] [PubMed] [Google Scholar]
  • 3.Germanakis I, Gardiner H. Assessment of fetal myocardial deformation using speckle tracking techniques. Fetal Diagn Ther. 2012;32(1–2):39–46. doi: 10.1159/000330378 [DOI] [PubMed] [Google Scholar]
  • 4.Nichting TJ, de Vet CM, van der Ven M, van der Woude DAA, Regis M, van Sloun RJG, et al. The impact of angles of insonation on left and right ventricular global longitudinal strain estimation in fetal speckle tracking echocardiography. PLoS One. 2023;18(7):e0287003. doi: 10.1371/journal.pone.0287003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Nichting TJ, van Lier ZA, de Vet C, van der Ven M, van der Woude DAA, Clur SA, et al. Feasibility and reliability of fetal two dimensional speckle tracking echocardiography at 16 weeks gestational age: A pilot study. PLoS One. 2024;19(4):e0302123. doi: 10.1371/journal.pone.0302123 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.van Oostrum NHM, van der Woude DAA, Clur S-AB, Oei SG, van Laar JOEH. Right ventricular dysfunction identified by abnormal strain values precedes evident growth restriction in small for gestational age fetuses. Prenat Diagn. 2020;40(12):1525–31. doi: 10.1002/pd.5805 [DOI] [PubMed] [Google Scholar]
  • 7.Clavero Adell M, Ayerza Casas A, Jiménez Montañés L, Palanca Arias D, López Ramón M, Alcalá Nalvaiz J-T, et al. Evolution of strain and strain rate values throughout gestation in healthy fetuses. Int J Cardiovasc Imaging. 2020;36(1):59–66. doi: 10.1007/s10554-019-01695-6 [DOI] [PubMed] [Google Scholar]
  • 8.Di Salvo G, Russo MG, Paladini D, Felicetti M, Castaldi B, Tartaglione A, et al. Two-dimensional strain to assess regional left and right ventricular longitudinal function in 100 normal foetuses. Eur J Echocardiogr. 2008;9(6):754–6. doi: 10.1093/ejechocard/jen134 [DOI] [PubMed] [Google Scholar]
  • 9.van Oostrum NHM, de Vet CM, Clur SB, van der Woude DAA, van den Heuvel ER, Oei SG, et al. Fetal myocardial deformation measured with two-dimensional speckle-tracking echocardiography: longitudinal prospective cohort study of 124 healthy fetuses. Ultrasound Obstet Gynecol. 2022;59(5):651–9. doi: 10.1002/uog.24781 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Köster HA, Hammer K, Braun J, Oelmeier de Murcia K, Möllers M, Klockenbusch W, et al. Comparison of strain and dyssynchrony measurements in fetal two-dimensional speckle tracking echocardiography using Philips and TomTec. J Perinat Med. 2020;48(3):266–73. doi: 10.1515/jpm-2019-0424 [DOI] [PubMed] [Google Scholar]
  • 11.Sacco A, Kazi A, Nzelu D, Jowett V, Pandya P. Feasibility and reproducibility of speckle tracking echocardiography in routine assessment of the fetal heart in a low-risk population. J Perinat Med. 2025;53(4):509–16. doi: 10.1515/jpm-2024-0514 [DOI] [PubMed] [Google Scholar]
  • 12.Crispi F, Sepulveda-Swatson E, Cruz-Lemini M, Rojas-Benavente J, Garcia-Posada R, Dominguez JM, et al. Feasibility and reproducibility of a standard protocol for 2D speckle tracking and tissue Doppler-based strain and strain rate analysis of the fetal heart. Fetal Diagn Ther. 2012;32(1–2):96–108. doi: 10.1159/000337329 [DOI] [PubMed] [Google Scholar]
  • 13.Matsuura Y, Daimon M, Notomi Y, Miyasaka N, Yamaguchi Y, Doi S. Feasibility and reproducibility of fetal left ventricular twist using two-dimensional speckle-tracking analysis in a Japanese population. Int Heart J. 2019;60(3):671–8. doi: 10.1536/ihj.18-480 [DOI] [PubMed] [Google Scholar]
  • 14.Kapusta L, Mainzer G, Weiner Z, Deutsch L, Khoury A, Haddad S, et al. Second trimester ultrasound: reference values for two-dimensional speckle tracking-derived longitudinal strain, strain rate and time to peak deformation of the fetal heart. J Am Soc Echocardiogr. 2012;25(12):1333–41. doi: 10.1016/j.echo.2012.09.011 [DOI] [PubMed] [Google Scholar]
  • 15.Huntley ES, Hernandez-Andrade E, Soto E, DeVore G, Sibai BM. Novel Speckle tracking analysis showed excellent reproducibility for size and shape of the fetal heart and good reproducibility for strain and fractional shortening. Fetal Diagn Ther. 2021;48(7):541–50. doi: 10.1159/000517625 [DOI] [PubMed] [Google Scholar]
  • 16.Hu W, Wang M, Bian J, Ding J, Liu W, Gu X. Evaluation of fetal cardiac morphology and function by fetal heart quantification technique in the normal second and third trimesters. Transl Pediatr. 2024;13(7):1106–18. doi: 10.21037/tp-24-123 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Chelliah A, Dham N, Frank LH, Donofrio M, Krishnan A. Myocardial strain can be measured from first trimester fetal echocardiography using velocity vector imaging. Prenat Diagn. 2016;36(5):483–8. doi: 10.1002/pd.4813 [DOI] [PubMed] [Google Scholar]
  • 18.DeVore GR, Polanco B, Satou G, Sklansky M. Two-dimensional speckle tracking of the fetal heart: a practical step-by-step approach for the fetal sonologist. J Ultrasound Med. 2016;35(8):1765–81. doi: 10.7863/ultra.15.08060 [DOI] [PubMed] [Google Scholar]
  • 19.Omdal TR, Khan U, Ebbing C, Kessler J, Karlsen HO, Leirgul E, et al. The influence of region of interest width in fetal 2D-speckle tracking echocardiography late in pregnancy. Int J Cardiovasc Imaging. 2022;38(4):719–25. doi: 10.1007/s10554-021-02455-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Semmler J, Day TG, Georgiopoulos G, Garcia-Gonzalez C, Aguilera J, Vigneswaran TV. Fetal speckle-tracking: impact of angle of insonation and frame rate on global longitudinal strain. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr. 2020;33:1141-1146.e2. doi: 10.1016/j.echo.2020.03.013 [DOI] [PubMed] [Google Scholar]
  • 21.Biswas M, Sudhakar S, Nanda NC, Buckberg G, Pradhan M, Roomi AU. Two‐ and three‐dimensional speckle tracking echocardiography: clinical applications and future directions. Echocardiography. 2013;30:88–105. doi: 10.1111/echo.12079 [DOI] [PubMed] [Google Scholar]
  • 22.Kapusta L, Mainzer G, Weiner Z, Deutsch L, Khoury A, Haddad S, et al. Changes in fetal left and right ventricular strain mechanics during normal pregnancy. J Am Soc Echocardiogr. 2013;26(10):1193–200. doi: 10.1016/j.echo.2013.06.007 [DOI] [PubMed] [Google Scholar]
  • 23.van Oostrum NHM, de Vet CM, van der Woude DAA, Kemps HMC, Oei SG, van Laar JOEH. Fetal strain and strain rate during pregnancy measured with speckle tracking echocardiography: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2020;250:178–87. doi: 10.1016/j.ejogrb.2020.04.002 [DOI] [PubMed] [Google Scholar]
  • 24.Mlodawski J, Zmelonek-Znamirowska A, Pawlik L, Mlodawska M, Swiercz G. Reproducibility challenges in fetal cardiac function analysis with 2D Speckle-Tracking echocardiography: insights from fetalHQ. J Clin Med. 2025;14(10):3301. doi: 10.3390/jcm14103301 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Di Tonto A, Nogue L, Valentini B, Bennasar M, Melito C, Sorrentino S, et al. Reproducibility analysis of two speckle tracking software for the antenatal semiautomated assessment of the fetal cardiac function. Fetal Diagn Ther. 2025;52(1):8–18. doi: 10.1159/000541007 [DOI] [PubMed] [Google Scholar]
  • 26.Enzensberger C, Achterberg F, Degenhardt J, Wolter A, Graupner O, Herrmann J, et al. Feasibility and reproducibility of two-dimensional wall motion tracking (WMT) in fetal echocardiography. Ultrasound Int Open. 2017;3(1):E26–33. doi: 10.1055/s-0042-124501 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.van Oostrum NHM, Oei SG, van Laar JOEH. Normal fetal cardiac deformation values in pregnancy; a prospective cohort study protocol. BMC Pregnancy Childbirth. 2019;19(1):524. doi: 10.1186/s12884-019-2662-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Bobak CA, Barr PJ, O’Malley AJ. Estimation of an inter-rater intra-class correlation coefficient that overcomes common assumption violations in the assessment of health measurement scales. BMC Med Res Methodol. 2018;18(1):93. doi: 10.1186/s12874-018-0550-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Arifin WN. Sample size calculator. Available from: https://wnarifin.github.io/ssc/ssicc.html. 2025.
  • 30.Walter SD, Eliasziw M, Donner A. Sample size and optimal designs for reliability studies. Stat Med. 1998;17(1):101–10. doi: 10.1002/(sici)1097-0258(19980115)17:1<101::aid-sim727>3.0.co;2-e [DOI] [PubMed] [Google Scholar]
  • 31.Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155–63. doi: 10.1016/j.jcm.2016.02.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Monti CB, Ambrogi F, Sardanelli F. Sample size calculation for data reliability and diagnostic performance: a go-to review. Eur Radiol Exp. 2024;8(1):79. doi: 10.1186/s41747-024-00474-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Kong KA. Statistical methods: reliability assessment and method comparison. Ewha Med J. 2017;40(1):9. doi: 10.12771/emj.2017.40.1.9 [DOI] [Google Scholar]
  • 34.Lee J-H, Park J-H. Strain analysis of the right ventricle using two-dimensional echocardiography. J Cardiovasc Imaging. 2018;26(3):111–24. doi: 10.4250/jcvi.2018.26.e11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Bonett DG. Sample size requirements for estimating intraclass correlations with desired precision. Stat Med. 2002;21(9):1331–5. doi: 10.1002/sim.1108 [DOI] [PubMed] [Google Scholar]
  • 36.Khalil A, Sotiriadis A, D’Antonio F, Da Silva Costa F, Odibo A, Prefumo F, et al. ISUOG practice guidelines: performance of third-trimester obstetric ultrasound scan. Ultrasound Obstet Gynecol. 2024;63(1):131–47. doi: 10.1002/uog.27538 [DOI] [PubMed] [Google Scholar]
  • 37.De Vet CM, Van Oostrum NHM, Clur SB, Oei SG, Van Laar JOEH. Re: correspondence on fetal myocardial deformation measured with two-dimensional speckle-tracking echocardiography: longitudinal prospective cohort study of 124 healthy fetuses: reply. Ultrasound Obstet Gynecol. 2023;62:448–9. doi: 10.1002/uog.26317 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Francesca Crovetto

7 May 2026

-->PONE-D-26-05691-->-->Reproducibility of fetal global longitudinal strain measured with speckle tracking echocardiography-->-->PLOS One

Dear Dr. Meireson,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jun 21 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:-->

  • A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only  the individual author can complete the verification step; PLOS staff cannot  verify ORCID iDs on behalf of authors.

We look forward to receiving your revised manuscript.

Kind regards,

Francesca Crovetto

Academic Editor

PLOS One

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that your Data Availability Statement is currently as follows: All relevant data are within the manuscript and its Supporting Information files.

Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition).

For example, authors should submit the following data:

- The values behind the means, standard deviations and other measures reported;

- The values used to build graphs;

- The points extracted from images for analysis.

Authors do not need to submit their entire data set if only a portion of the data was used in the reported study.

If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories.

If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access.

3. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

-->Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. -->

Reviewer #1: Yes

Reviewer #2: Partly

**********

-->2. Has the statistical analysis been performed appropriately and rigorously? -->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: Yes

Reviewer #2: No

**********

-->4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)-->

Reviewer #1: I have carefully reviewed the manuscript entitled “Reproducibility of fetal global longitudinal strain measured with speckle tracking echocardiography” . Overall, I find it to be a well-conducted and relevant study addressing an important limitation in fetal cardiology, namely the variability of fSTE measurements that currently limits clinical implementation.

The manuscript is generally well structured, with a clear objective and a solid methodological approach. I particularly appreciate the use of a standardized protocol and the decision to analyze the same heart cycle within a single DICOM clip, which represents a meaningful methodological strength. The relatively large sample size further enhances the reliability of the findings.

The results are clearly presented and show that reproducibility is variable, with better performance in the left ventricle and before 32 weeks of gestation. The finding of higher inter-observer than intra-observer reproducibility is interesting and deserves further emphasis. What I found particularly valuable is the clarity with which the methodological steps are described, especially the detailed explanation of the fSTE analysis workflow. This makes the study easy to follow and gives confidence in the reproducibility of the approach.

That said, a few aspects could be improved. The introduction could better highlight the novelty of the study, and the methods section would benefit from more detail regarding operator experience and selection criteria. In the discussion, some sections are slightly repetitive, and the clinical implications of the findings could be more clearly articulated. Additionally, limitations related to generalizability and software dependence should be expanded.

The manuscript includes a limited number of citations from the authors’ previous work, which appear appropriate given the continuity of the research and the use of an established cohort and methodology.

In conclusion, this is a valuable and methodologically sound study. With minor to moderate revisions, particularly to improve clarity and strengthen the discussion, the manuscript would be suitable for publication.

Reviewer #2: The authors make a pretty reasonable atempt to separate the soruces of variability in fSTE by analyzing the same cardiac cycle in the same DICOM clip, which by itself is valuable and honestly more precise then many earlier studies.

My comments on the manuskript:

The authors state that the cohort included 124 women, while the inter-observer analysis was performed on 136 independent ultrasound clips, and at the same time they write they used “only independent data, with one DICOM clip per patient”. These three pieces of information cannot really be reconciled logicaly.

The authors write that for the sample size calculation they set threshold = 0.75 and expected reliability = 0.60. In the classical aproach to planning an ICC reliability study, the expected value should be higher then the minimally acceptable one, not lower. In the present wording it looks like the study was powered to show that the expected reliabilty is worse than the preset threshold. This suggests either the parameters were described in reverse, or the calculation itself was done incorretly.

The authors admit that the clips for the inter-observer analysis came from the gestational age category with the highest reproducibility in the intra-observer subanalysis, and in the end they mostly covered 25 to 30 weeks, with predominance of week 27. This means the inter-observer analysis was not a representative assesment of the whole 18 to 41 week range, but rather an assesment done in a priviliged, preselected fragment of the data.

In both the intra-observer and inter-observer settings, the authors efectively freeze steps 1 and 2, meaning clip selection and cardiac cycle selection. The second intra-observer analysis starts from step 3, and in the inter-observer setting the second observer uses the clip and cycle previously selected by the first observer. So in practice the study does not assess full reproducibility of GLS measurement, but only reproducibility of manual segmentation/contouring and GLS calculation after the clip and cycle had already been fixed. This does not fully invalidate the work, but it needs a more honest naming. The current title and abstract are too broad. This should already be stated in the title, abstract and conclusions.

In the discussion the authors themself write that observer one became more precise after her second own measurement and then trained observer two, while the inter-observer analysis was calculated using the second measurement of observer one and the measurement of observer two. This is not a neutral circumstnace. It means the observers were not simply two independent readers, but that the second observer entered the analysis after a stage of harmonisation with the first one. Such a setup may artifically increase agreement and should be treated as a serious limitation, not only as a possible explanation of the resutls.

The authors correctly criticize the literature for imprecise ICC reporting, but they themself do not provide the most important information, namely which exact ICC model was used. The mere statement that ICC was estimated by LMM does not solve the interpretative problem. Also, p-values are attached to tables labeled as ICC tables, but it is not clearly stated whether these are p-values for the ICC test or for the paired t-test related to bias.

The whole intra-observer analysis includes 632 clips from 124 patients, so the observations are not independent. The authors use LMM for ICC, which is reasonable, but the Bland-Altman plots and paired t-tests are described as if all clips were treated like independent pairs of measurments. With repeated measurements from the same fetuses, the classical Bland-Altman method may give incorrect limits of agreement if the repeated-measures structure is not taken into account. In this work either a repeated-measures Bland-Altman aproach or a mixed-effects aproach to agreement is needed, or at least a clear discussion of this limitation.

The most striking aspect of the intra-observer results is not the ICC itself, but the absolute width of the LoA. For the LV, the mean difference is 0.16, but the limits of agreement go to about -11.34 and +11.67, and for the RV about -11.71 to +12.34. With mean GLS values around -21% and -19%, this is a very wide spread. In other words, even with a “moderate” ICC, the clinical interchangebility of single measurements may still be weak.

The conclusion about the “highest reproducibility before 32 weeks” is too strong. The authors show descriptively that some ICC values are highest in the 23 to 27 and 28 to 32 week groups. But they did not perform a formal comparison of ICCs between gestational age groups, they did not show an interaction test, and the confidence intervals overlap to a large extent. In additon, the inter-observer analysis was intentionally built on material from exactly this range. In this situation, the statement in the abstract and conclusion that reproducibility is highest before 32 weeks is more narrative then evidence-based. It should be softened to a descriptive observation.

In the limitations section the authors write that both intra- and inter-observer reproducibility analyses demonstrated statistically significant ICCs, which is not consistant with the tables, where p-values for intra-observer are 0.499 and 0.221, and for inter-observer LV 0.298.

In the discussion there is a sentence saying that “two of the eight studies” did not report 95% CI, but three papers are cited there: [14], [22], and [26].

Table 4 does not match the authors’ own results. The row “Our study” contains numbers and CIs that do not correspond to Tables 1 and 3. In particular, RV inter-observer in Table 4 is given as 0.71 [0.61-0.78], while Table 3 shows 0.625 [0.426-0.777].

In the Methods, the authors refer to an earlier description of the cohort, but even in this manuskript the basic information is still needed: exact inclusion and exclusion criteria, number of women assessed for eligibilty, number excluded, number of failed or non-analyzable clips, distribution of number of visits per patient, reasons for missing data, and ideally a flow diagram. Without this, it is imposible to judge whether the analyzed clips were a representative subset of the material or rather a selected set of technically best examinations.

The data statement says: “All relevant data are within the manuscript and its Supporting Information files”, but in the submitted draft there are no actual source data allowing the reader to reproduce the reproducibility analyses for 632 clips and 3 reading series. If the relevant dataset is supposed to be in the supplementary material, it should be actually attached and described. Otherwise the statement is incomplete or misleaading.

The authors did not consider angle of insonation because previous data supposedly suggested angle-independence. However, their own bibliography includes papers dealing with the effect of angle and frame rate on GLS, and in the discussion they themself admit that previous studies also differed in this respect.

Overall, I think the manuskript may become suitable for publication, but only after an apropriate major revision.

**********

-->6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review?  For information about this choice, including consent withdrawal, please see our Privacy Policy.-->

Reviewer #1: Yes:  Cerghit-Paler Andreea

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

PLoS One. 2026 Jul 31;21(7):e0354514. doi: 10.1371/journal.pone.0354514.r002

Author response to Decision Letter 1


16 Jun 2026

Ghent University

Human structure and repair

Corneel Heymanslaan 10

9000 Gent, Belgium

Dear Francesca Crovetto,

On behalf of all the authors, I hereby kindly submit our revised manuscript entitled “Reproducibility of fetal global longitudinal strain measured with speckle tracking echocardiography using a fixed cardiac cycle” (reference number: PONE-D-26-05691).

We appreciate the opportunity to revise our manuscript and are grateful to you and the reviewers for the constructive and detailed feedback. We have carefully addressed all comments and believe that the revisions have strengthened the manuscript.

Please find attached a point-by-point response to the reviewers’ comments. All changes made in the manuscript are also clearly indicated in the track-changes version.

Please address all correspondence concerning this manuscript to: eline.meireson@ugent.be

Thank you for considering our manuscript.

With kind regards,

Eline Meireson, PhD student

Chantelle de Vet, MD, PhD, consultant physician

Judith O.E.H. van Laar, MD, PhD, consultant obstetrician, associated professor TU/e

Phaedra Mussche, master student biomedical science

Prof. Kristien Roelens, MD, PhD, consultant obstetrician

Noortje H. M. van Oostrum, MD, PhD, consultant obstetrician

Attachment

Submitted filename: Response to Reviewers_12.06.26.docx

pone.0354514.s003.docx (29.1KB, docx)

Decision Letter 1

Francesca Crovetto

10 Jul 2026

Reproducibility of fetal global longitudinal strain measured with speckle tracking echocardiography using a fixed cardiac cycle

PONE-D-26-05691R1

Dear Dr. Meireson

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Francesca Crovetto

Academic Editor

PLOS One

Acceptance letter

Francesca Crovetto

PONE-D-26-05691R1

PLOS One

Dear Dr. Meireson,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Francesca Crovetto

Academic Editor

PLOS One

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Dataset intra-observer reproducibility.

    (XLSX)

    pone.0354514.s001.xlsx (40.3KB, xlsx)
    S2 File. Dataset interobserver reproducibility.

    (XLSX)

    pone.0354514.s002.xlsx (14.2KB, xlsx)
    Attachment

    Submitted filename: Response to Reviewers_12.06.26.docx

    pone.0354514.s003.docx (29.1KB, docx)

    Data Availability Statement

    All relevant data are within the paper and its Supporting information files.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES